Vitamin D Council needs your help...

Tax-deductible!

Together we can end the illness and disease caused by the worldwide epidemic of vitamin D deficiency.

About Vitamin D Council

Contact Vitamin D Council

Sponsor Vitamin D Council

Follow us on:

Vitamin D Products

(off-site)

These companies donate to the Vitamin D Council.

D-Lite, Renew, & SunSplash UV/Tanning Systems
In-Home ZRT Vitamin D Blood Test Kit
Get Premium Quality Vitamin D Supplements at Great Prices
Vitamin D3 Plus™ from Bio-Tech — contains the cofactors Vitamin D needs to work properly.

Vitamin D Research

back to research menu

Parathyroid Function

Regulation of vitamin D receptor function in MEN1-related parathyroid adenomas. Mol Cell Endocrinol. 2009 Dec 10;313(1–2):1–8.
Parathyroid Hormone as a Mortality Predictor in Frail Aged Inpatients. Gerontology. 2009 Sep 15.
Hyperparathyroidism and vitamin D deficiency predispose to bone loss in renal transplant recipients. Transplantation. 2009 Sep 15;88(5):678–83.
Human PTH gene regulation in vivo using transgenic mice. Am J Physiol Renal Physiol. 2009 Sep;297(3):F713–9.
The full-length calcium-sensing receptor dampens the calcemic response to 1alpha,25(OH)2 vitamin D3 in vivo independently of parathyroid hormone. Am J Physiol Renal Physiol. 2009 Sep;297(3):F720–8.
Potential for vitamin D receptor agonists in the treatment of cardiovascular disease. Br J Pharmacol. 2009 Sep;158(2):395–412.
Vitamin D and parathyroid hormone in general populations: understandings in 2009 and applications to chronic kidney disease. Clin J Am Soc Nephrol. 2009 Sep;4(9):1508–14.
Indirect regulation of PTH by estrogens may require FGF23. J Am Soc Nephrol. 2009 Sep;20(9):2009–17.
Vitamin D status, bone mineral density, and inflammation in kidney transplantation patients. Transplant Proc. 2009 Sep;41(7):2823–5.
Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the VDR in parathyroid physiology. Am J Physiol Renal Physiol. 2009 Aug 19.
The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats. Eur J Pharmacol. 2009 Aug 15;616(1–3):306–13.
Successful treatment of postsurgical hypoparathyroidism by intramuscular injection of vitamin D(3) in a patient associated with malabsorption syndrome due to multiple abdominal surgeries. J Bone Miner Metab. 2009 Aug 6.
Prevalence and Associations of 25-Hydroxyvitamin D Deficiency in US Children: NHANES 2001–2004. Pediatrics. 2009 Aug 3.
Total parathyroidectomy without autotransplantation in dialysis patients and renal transplant recipients, long-term follow-up evaluation. Am J Surg. 2009 Aug;198(2):178–83.
Calcium, parathyroid hormone, and vitamin D: major determinants of chronic pain in hemodialysis patients. Clin J Am Soc Nephrol. 2009 Aug;4(8):1374–80.
Secondary causes of low bone mass in patients with breast cancer: a need for greater vigilance. J Clin Oncol. 2009 Aug 1;27(22):3605–10.
Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J Pediatr. 2009 Aug;155(2):260–5.
High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int. 2009 Aug;20(8):1407–15.
Potential of alfacalcidol for reducing increased risk of falls and fractures. Rheumatol Int. 2009 Aug;29(10):1177–85.
Relationship of vitamin D and parathyroid hormone to obesity and body composition in African Americans. Clin Endocrinol (Oxf). 2009 Jul 28.
Improvement of impaired calcium and skeletal homeostasis in vitamin D receptor knockout mice by a high dose of calcitriol and maxacalcitol. Bone. 2009 Jul 23.
Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Bone. 2009 Jul 23.
The negative effect of dexamethasone on calcium-processing gene expressions is associated with a glucocorticoid-induced calcium-absorbing disorder. Life Sci. 2009 Jul 17;85(3–4):146–52.
Hyperparathyroidism. Lancet. 2009 Jul 11;374(9684):145–58. Review.
Altered calcium metabolism in patients on long-term bisphosphonate therapy for metastatic breast cancer. Anticancer Res. 2009 Jul;29(7):2707–11.
Calcium malabsorption does not cause secondary hyperparathyroidism. Calcif Tissue Int. 2009 Jul;85(1):31–6.
Hormones and osteoporosis update. Vitamin D and bone. Clin Calcium. 2009 Jul;19(7):920–8.
Is replacement therapy with nutritional and active forms of vitamin D required in chronic kidney disease mineral and bone disorder? Curr Opin Nephrol Hypertens. 2009 Jul;18(4):308–14.
Adynamic bone disease: clinical and therapeutic implications. Curr Opin Nephrol Hypertens. 2009 Jul;18(4):303–7.
Vitamin D in diabetes mellitus-a new field of knowledge poised for D-velopment. Diabetes Metab Res Rev. 2009 Jul;25(5):417–9.
Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D. Eur J Endocrinol. 2009 Jul;161(1):189–93.
Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols. Pediatr Nephrol. 2009 Jul;24(7):1355–61.
Cinacalcet-Induced Leukocytoclastic Vasculitis. Am J Kidney Dis. 2009 Jun 26.
Hyperparathyroidism secondary to maternal hypoparathyroidism and vitamin D deficiency: an uncommon cause of neonatal respiratory distress. Ann Trop Paediatr. 2009 Jun;29(2):149–54.
Comparison of oral falecalcitriol and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism: a randomized, crossover trial. Clin Nephrol. 2009 Jun;71(6):660–8.
Paricalcitol and outcome: a manual on how a vitamin D receptor activator (VDRA) can help us to get down the "U". Clin Nephrol. 2009 Jun;71(6):593–601.
Low parathyroid hormone levels in bedridden geriatric patients with vitamin D deficiency. J Am Geriatr Soc. 2009 Jun;57(6):1045–50.
Vitamin D insufficiency and deficiency in children with early chronic kidney disease. J Pediatr. 2009 Jun;154(6):906–11.e1.
FGF23 in chronic kidney disease and kidney post-transplant patients. Nefrologia. 2009 Jun;29(3):196–202.
Resistance to vitamin D treatment as an indication of celiac disease in a patient with primary hypoparathyroidism. Clinics. 2009 Jun;64(3):259–61.
Poor vitamin D status may contribute to high risk for insulin resistance, obesity, and cardiovascular disease in Asian Indians. Med Hypotheses. 2009 Jun;72(6):647–51.
Hypoparathyroidism associated with severe mineral bone disease postrenal transplantation, treated successfully with recombinant PTH. Hemodial Int. 2009 May 28.
Pivotal Role of Paricalcitol in the Treatment of Calcific Uremic Arteriolopathy in the Presence of a Parathyroid Adenoma. Am J Kidney Dis. 2009 May 27.
Hip fractures in a developing country: Osteoporosis frequency, predisposing factors and treatment costs. Arch Gerontol Geriatr. 2009 May 27.
Primary hyperparathyroidism : Postoperative normocalcemic hyperparathyrinemia after curative parathyroidectomy. Chirurg. 2009 May 27.
Inhibition of markers of bone resorption by consumption of vitamin D and calcium-fortified soft plain cheese by institutionalised elderly women. Br J Nutr. 2009 May 18:1–5.
Vitamin D deficiency and supplementation during pregnancy. Clin Endocrinol (Oxf). 2009 May;70(5):685–90.
Unusually severe phenotype of neonatal primary hyperparathyroidism due to a heterozygous inactivating mutation in the CASR gene. Eur J Pediatr. 2009 May;168(5):569–73.
Can moderate elevations of parathyroid hormone acutely increase risk for ischemic cardiac arrhythmias? Med Hypotheses. 2009 May;72(5):581–3.
Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice. Gastroenterology. 2009 Apr;136(4):1317–27, e1–2.
Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients. Bone. 2009 Apr;44(4):678–83.
Hip fractures in the elderly in Israel—possible impact of preventable conditions. Arch Gerontol Geriatr. 2009 Mar–Apr;48(2):182–5.
Responses of parathyroid hormone to vitamin D supplementation: a systematic review of clinical trials. Arch Gerontol Geriatr. 2009 Mar–Apr;48(2):160–6.
Calcium and Phosphorus Homeostasis. Blood Purif. 2009 Mar 23;27(4):387–394.
Utilization of Preoperative Patient Factors to Predict Postoperative Vitamin D Deficiency for Patients Undergoing Gastric Bypass. J Gastrointest Surg. 2009 Mar 13.
Determinants of 25-hydroxyvitamin D levels in African-American and Caucasian male veterans. Osteoporos Int. 2009 Mar 12.
Calcium-Sensing Receptor Expression is Regulated by Glial Cells Missing-2 in Human Parathyroid Cells. J Bone Miner Res. 2009 Mar 3.
Behavioural and physical characteristics associated with vitamin D status in women. Bone. 2009 Mar 2.
Vitamin D metabolism and vitamin D traditional and nontraditional, target organs: implications for kidney patients. J Ren Care. 2009 Mar;35 Suppl 1:39–44.
Effects of platelet-derived growth factor, vitamin D and parathyroid hormone on osteoblasts derived from cancer patients on chronic bisphosphonate therapy. Int J Mol Med. 2009 Mar;23(3):407–13.
The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD. Am J Kidney Dis. 2009 Mar;53(3):408–16.
Direct upregulation of parathyroid calcium-sensing receptor and vitamin D receptor by calcimimetics in uremic rats. Am J Physiol Renal Physiol. 2009 Mar;296(3):F605–13.
Absence of adynamic bone disease in African- Americans with CKD Stage 5 after 3 years of vitamin D therapy guided by iPTH and the PTH-(1-84)/N-terminally truncated PTH fragments ratio. Clin Nephrol. 2009 Mar;71(3):267–75.
Presence of 25(OH)D deficiency and its effect on vitamin D receptor mRNA expression. Eur J Clin Nutr. 2009 Mar;63(3):446–9.
Age-related bone loss in the LOU/c rat model of healthy ageing. Exp Gerontol. 2009 Mar;44(3):183–9.
Vitamin D status and muscle function in post-menarchal adolescent girls. J Clin Endocrinol Metab. 2009 Feb;94(2):559–63.
Seasonal variance of 25-(OH) vitamin D in the general population of Estonia, a Northern European country. BMC Public Health 2009 Jan 19, 9:22.
Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift? Nat Clin Pract Nephrol. 2009 Jan;5(1):24–33.
Association of Serum Intact Parathyroid Hormone with Lower Estimated Glomerular Filtration Rate. Clin J Am Soc Nephrol. 2009 Jan;4(1):186–94.
Ultrasound bone mass in schizophrenic patients on antipsychotic therapy. Hum Psychopharmacol. 2009 Jan;24(1):49–54.
Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2009 Jan;94(1):26–34.
Rheumatic manifestations of renal disease. Curr Opin Rheumatol. 2009 Jan;21(1):55–61. Review.
Prevalence of vitamin D deficiency rickets in the eastern part of Turkey. Eur J Pediatr. 2009 Jan;168(1):95–100.
Analysis of CYP27B1, encoding 25-hydroxyvitamin D-1alpha-hydroxylase, as a candidate tumor suppressor gene in primary and severe secondary/tertiary hyperparathyroidism. J Bone Miner Res. 2009 Jan;24(1):102–4.
Vitamin d deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 2008 Dec 9;52(24):1949–56.
A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet. Eur J Endocrinol. 2008 Dec;159 Suppl 1:S101–5.
Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med. 2008 Dec;264(6):599–609.
Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial? Surgery. 2008 Dec;144(6):852–8; discussion 858–9.
Vitamin D analogs: Therapeutic applications and mechanisms for selectivity. Mol Aspects Med. 2008 Dec;29(6):433–52.
Role of bone biopsy in stages 3 to 4 chronic kidney disease. Clin J Am Soc Nephrol. 2008 Nov;3 Suppl 3:S170–4.
Vitamin D and musculoskeletal health. Nat Clin Pract Rheumatol. 2008 Nov;4(11):580–8.
Vitamin D Deficiency among HIV Type 1-Infected Individuals in the Netherlands: Effects of Antiretroviral Therapy. AIDS Research and Human Retroviruses. 2008 Oct. 18. Vol. 4 No. 11.
Urban tropospheric ozone increases the prevalence of vitamin D deficiency among Belgian postmenopausal women with outdoor activities during summer. J Clin Endocrinol Metab. 2008 Oct;93(10):3893–9.
Vitamin D: a rapid review. Urol Nurs. 2008 Oct;28(5):343–9, 384; quiz 350.
Markers of bone and calcium metabolism following gastric bypass and laparoscopic adjustable gastric banding. Obes Surg. 2008 Sep;18(9):1144–8.
High bone turnover but normal bone mineral density in women suffering from schizophrenia. Psychol Med. 2008 Aug;38(8):1195–201.
African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox. Am J Clin Nutr. 2008 Aug;88(2):545S–550S. Review.
25-Hydroxyvitamin D: functional outcomes in infants and young children. Am J Clin Nutr. 2008 Aug;88(2):529S–533S. Review.
Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol. 2008 Aug;19(8):1509–19.
Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol. 2008 Jul;3(4):1144–51.
Effect on bone density of postoperative calcium and vitamin-D supplementation in patients with primary hyperparathyroidism: A retrospective study. Langenbecks Arch Surg. 2008 Jun 11.
Hypovitaminosis D among healthy children in the United States: a review of the current evidence. Arch Pediatr Adolesc Med. 2008 Jun;162(6):513–9. Review.
Mineral metabolism and bone abnormalities in children with chronic renal failure. Rev Endocr Metab Disord. 2008 Jun;9(2):131–7. Review.
Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone. Arch Biochem Biophys. 2008 May 15;473(2):218–24. Review.
Healthy children with frequent fractures: how much evaluation is needed? Pediatrics. 2008 May;121(5):890–7.
Depression Is Associated With Decreased 25-Hydroxyvitamin D and Increased Parathyroid Hormone Levels in Older Adults. Arch Gen Psychiatry. 2008 May;65(5):508–512
Long-term outcome after parathyroidectomy in patients with advanced primary hyperparathyroidism and associated vitamin D deficiency. World J Surg. 2008 May;32(5):829–35.
Pakistani immigrant children and adults in Denmark have severely low vitamin D status. Eur J Clin Nutr. 2008 May;62(5):625–34.
Vitamin D status in postmenopausal women living at higher latitudes in the UK in relation to bone health, overweight, sunlight exposure and dietary vitamin D. Bone. 2008 May;42(5):996–1003.
Generalized metabolic bone disease in Neurofibromatosis type I. Mol Genet Metab. 2008 May;94(1):105–11.
The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells. Clin Exp Rheumatol. 2008 Mar–Apr;26(2):295–304.
Hypercalcemia in malignancies of the female genital tract. Harefuah. 2008 Mar;147(3):229–34, 277. In Hebrew.
Vitamin D status in Andhra Pradesh : a population based study. Indian J Med Res. 2008 Mar;127(3):211–8.
Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism. 2008 Feb;57(2):183–91.
A longitudinal study of serum 25-hydroxyvitamin D and intact PTH levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):152–7.
Vitamin D supplementation has minor effects on parathyroid hormone and bone turnover markers in vitamin D-deficient bedridden older patients. Age Ageing. 2008 Jan;37(1):25–31.
Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis). Nefrologia. 2008;28 Suppl 3:67–78. In Spanish.
The effect of a single dose versus a daily dose of cholecalciferol on the serum 25-hydroxycholecalciferol and parathyroid hormone levels in the elderly with secondary hyperparathyroidism living in a low-income housing unit. J Bone Miner Metab. 2008;26(6):603–8.
Vitamin D deficiency and primary hyperparathyroidism. J Bone Miner Res. 2007 Dec;22 Suppl 2:V100–4. Review.
Vitamin D insufficiency/deficiency in gastrointestinal disorders. J Bone Miner Res. 2007 Dec;22 Suppl 2:V50–4. Review.
Vitamin D and its implications for musculoskeletal health in women: An update. Maturitas. 2007 Oct 20;58(2):117–37. Review.
Vitamin D and muscle strength in patients with previous fractures. N Z Med J. 2007 Sep 21;120(1262):U2730.
Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1–235. Review.
Identification and functional characterization of a novel mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia: modulation of clinical severity by vitamin D status. J Clin Endocrinol Metab. 2007 Jul;92(7):2616–23.
Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis. 2007 Jul;50(1):59–68.
Relationships between myocardial injury, all-cause mortality, vitamin D, PTH, and biochemical bone turnover markers in older patients with hip fractures. Ann Clin Lab Sci. 2007 Summer;37(3):222–32.
Vitamin d and rehabilitation: improving functional outcomes. Nutr Clin Pract. 2007 Jun;22(3):297–304. Review.
Effect of 2-Methylene-19-nor-(20S)-1alpha-Hydroxy- Bishomopregnacalciferol (2MbisP), an Analog of Vitamin D, on Secondary Hyperparathyroidism. J Bone Miner Res. 2007 May;22(5):686–94.
The incidence of osteopenia and osteoporosis in women with hip osteoarthritis scheduled for cementless total joint replacement. Bone. 2007 Apr;40(4):1041–7.
Vitamin D and Parathyroid Hormone in Outpatients With Noncholestatic Chronic Liver Disease. Clin Gastroenterol Hepatol. 2007 Apr;5(4):513–20.
Vitamin D analogs for secondary hyperparathyroidism: What does the future hold? J Steroid Biochem Mol Biol. 2007 Mar;103(3–5):578–83.
Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):134–44. Review.
Osteomalacia and secondary hyperparathyroidism after kidney transplantation: Relationship to vitamin D deficiency. Am J Med Sci. 2007 Jan;333(1):58–62.
Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function. Clin Endocrinol (Oxf). 2007 Jan;66(1):35–42.
Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study. Nephron Clin Pract. 2007;107(3):c109–16.
Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol. 2007;27(1):36–43.
Effects of parathyroidectomy on bone remodeling markers and vitamin D status in patients with chronic kidney disease-mineral and bone disorder. Int Urol Nephrol. 2007;39(4):1251–6.
Relationships between Myocardial Injury, All-cause Mortality, Vitamin D, PTH, and Biochemical Bone Turnover Markers in Older Patients with Hip Fractures.Annals of Clinical and Laboratory Science 37:222–232 (2007).
Synthesis and evaluation of a 3-position diastereomer of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D(3) (ED-71). Bioorg Med Chem. 2006 Dec 1;14(23):8050–6.
Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysis. Clin Nephrol. 2006 Oct;66(4):247–55.
Distinct association of gene polymorphisms of estrogen receptor and vitamin D receptor with lumbar spondylosis in post-menopausal women. Eur Spine J. 2006 Oct;15(10):1521–8.
Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients. Pediatr Nephrol. 2006 Oct;21(10):1434–9.
Postpartum vitamin D insufficiency and secondary hyperparathyroidism in healthy Danish women. Eur J Clin Nutr. 2006 Oct;60(10):1214–21.
Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am J Clin Nutr. 2006 Sep;84(3):602–9.
Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients. Nephrol Dial Transplant. 2006 Sep;21(9):2621–4.
Regression of Skeletal Manifestations of Hyperparathyroidism with Oral Vitamin D. Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 7 2480–2483.
Vitamin D physiology. Prog Biophys Mol Biol. 2006 Sep;92(1):4–8. Review.
Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study. Eur J Endocrinol. 2006 Aug;155(2):237–44.
Effects of depleted uranium after short-term exposure on vitamin D metabolism in rat. Arch Toxicol. 2006 Aug;80(8):473–480.
Osteoporotic fractures and vitamin D deficiency. Aust Fam Physician. 2006 Jul;35(7):519–20, 522.
A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism. J Endocrinol Invest. 2006 Jun;29(6):511–5.
Effect of vitamin D supplementation on vitamin D status and bone turnover markers in young adults. Eur J Clin Nutr. 2006 Jun;60(6):727–33.
The long-term effects of gastric bypass on vitamin D metabolism. Ann Surg. 2006 May;243(5):701–4; discussion 704–5.
Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence. Calcif Tissue Int. 2006 May;78(5):257–70. Review.
Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab. 2006 May;290(5):E916–24.
The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese Black Americans. Clin Endocrinol (Oxf). 2006 May;64(5):523–9.
Vitamin D and African Americans. J Nutr. 2006 Apr;136(4):1126–9.
Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromso study. J Neurol. 2006 Apr;253(4):464–70.
Vitamin D status of 51–75-year-old Irish women: its determinants and impact on biochemical indices of bone turnover. Public Health Nutr. 2006 Apr;9(2):225–33.
Correlations between vitamin D status and biochemical/clinical and pathological parameters in primary hyperparathyroidism. World J Surg. 2006 Mar;30(3):321–6.
Severe vitamin D deficiency in Hawai'i: a case report. Hawaii Med J. 2006 Jan;65(1):16–17, 20.
Prospective study of perioperative factors predicting hypocalcemia after thyroid and parathyroid surgery. Arch Otolaryngol Head Neck Surg. 2006 Jan;132(1):41–5.
Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int. 2006 Jan;69(1):33–43. Review.
Threshold value of serum 25-hydroxyvitamin D concentration in relation to elevated serum parathyroid hormone concentrations in elderly Japanese women. J Bone Miner Metab. 2006;24(5):395–400.
Vitamin D and intact PTH status in patients with hip fracture. Osteoporos Int. 2006;17(11):1608–14.
Causes of secondary hyperparathyroidism in a healthy population: the Tromso study. J Bone Miner Metab. 2006;24(1):58–64.
25-hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy. Surgery. 2005 Dec;138(6):1018–25; discussion 1025–6.
Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: the Rancho Bernardo Study. Osteoporos Int. 2005 Dec;16(12):1721–6.
Inhibition of parathyroid hormone: a dose equivalency study of paricalcitol and doxercalciferol. Am J Nephrol. 2005 Nov–Dec;25(6):591–5.
Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA. 2005 Nov 9;294(18):2336–41.
Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease? Kidney Int. 2005 Nov;68(5):1973–81. Review.
Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf). 2005 Nov;63(5):506–13.
Nutrition, mild hyperparathyroidism, and bone mineral density in young Japanese women. Am J Clin Nutr. 2005 Nov;82(5):1127–33.
25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy. Kidney Int. 2005 Oct;68(4):1840–8.
The role of vitamin D in vascular calcification in chronic kidney disease. Semin Dial. 2005 Jul–Aug;18(4):307–14. Review.
Vitamin D for health and in chronic kidney disease. Semin Dial. 2005 Jul–Aug;18(4):266–75. Review.
Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis. 2005 Jun;45(6):1026–33.
Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis. Pediatr Nephrol. 2005 May;20(5):622–30.
Vitamin D status of 51–75-year-old Irish women: its determinants and impact on biochemical indices of bone turnover. Public Health Nutr. 2006 Apr;9(2):225–33.
Prevalence of vitamin D insufficiency in postmenopausal south Indian women. Osteoporos Int. 2005 Apr;16(4):397–402.
Parathyroid hormone decreases renal vitamin D receptor expression in vivo. Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4724–8.
There is no lower threshold level for parathyroid hormone as 25-hydroxyvitamin D concentrations increase. J Endocrinol Invest. 2005 Feb;28(2):183–6. Review.
Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients? J Nephrol. 2005 Jan–Feb;18(1):96–101.
Low levels of 25-hydroxyvitamin D are associated with elevated parathyroid hormone in healthy adolescent females. Osteoporos Int. 2005 Jan;16(1):109–13.
Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study. Ren Fail. 2005;27(2):205–12.
Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density. Am J Clin Nutr. 2004 Dec;80(6):1645–9.
Failure to normalize parathyroid hormone during treatment of vitamin D deficiency in Asian patients. Clin Endocrinol (Oxf). 2004 Nov;61(5):603–6.
High ratio of 1,25-dihydroxyvitamin D3 to parathyroid hormone in serum of tuberculous patients with end-stage renal disease. Clin Nephrol. 2004 Sep;62(3):202–7.
Disturbances of calcium-PTH-vitamin D axis in chronic liver diseases. Arq Bras Endocrinol Metabol. 2004 Aug;48(4):443–50. Review.
Serum parathyroid hormone level is associated with body mass index. The 5th Tromso study. Eur J Endocrinol. 2004 Aug;151(2):167–72.
Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res. 2004 Aug;19(8):1221–30.
The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone. 2004 Jul;35(1):312–9.
Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol. 2004 May;89–90(1–5):611–4. Review.
A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NONOF) Study. Age Ageing. 2004 Jan;33(1):45–51.
Bone density, parathyroid hormone, calcium and vitamin D nutritional status of institutionalized elderly subjects. J Nutr Health Aging. 2004;8(5):400–4.
Effects of vitamin D supplementation on strength, physical function, and health perception in older, community-dwelling men. J Am Geriatr Soc. 2003 Dec;51(12):1762–7.
Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the Minos study. Calcif Tissue Int. 2003 Dec;73(6):520–30.
Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepubertal Finnish girls. Am J Clin Nutr. 2003 Sep;78(3):485–92.
The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects. J Clin Endocrinol Metab. 2003 Aug;88(8):3501–4.
Vitamin D supplementation to healthy children does not affect serum osteocalcin or markers of type I collagen turnover. Acta Paediatr. 2003 Jul;92(7):797–801.
New vitamin D analogs. Kidney Int Suppl. 2003 Jun;(85):S83–7. Review.
Vitamin D status and secondary hyperparathyroidism: the importance of 25-hydroxyvitamin D cut-off levels. Kidney Int Suppl. 2003 Jun;(85):S44–8.
Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection. Gut. 2003 May;52(5):653–8.
Rescue of the pseudo-vitamin D deficiency rickets phenotype of CYP27B1-deficient mice by treatment with 1,25-dihydroxyvitamin D3: biochemical, histomorphometric, and biomechanical analyses. J Bone Miner Res. 2003 Apr;18(4):637–43.
Assessment of vitamin D and calcium status in healthy adult Austrians. Eur J Clin Invest. 2003 Apr;33(4):323–31.
Effects of calcitriol on parathyroid function and on bone remodelling in secondary hyperparathyroidism. Nephrol Dial Transplant. 2003 Apr;18(4):743–9.
Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab. 2003 Jan;88(1):185–91.
Review of the concept of vitamin D "sufficiency and insufficiency." Nefrologia. 2003;23 Suppl 2:73–7. Review.
Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol Endocrinol. 2002 Jul;16(7):1524–37.
Renal failure and vitamin D. Clin Calcium. 2002 Jun;12(6):711–23. In Japanese.
Vitamin D analogs: new therapeutic agents for secondary hyperparathyroidism. Treat Endocrinol. 2002;1(5):313–27. Review.
Vitamin D analogues for secondary hyperparathyroidism. Nephrol Dial Transplant. 2002;17 Suppl 10:10–9. Review.
Vitamin D analogs for the treatment of secondary hyperparathyroidism. Blood Purif. 2002;20(1):109–12. Review.
Vitamin D analogues for the management of secondary hyperparathyroidism. Am J Kidney Dis. 2001 Nov;38(5 Suppl 5):S34–40. Review.
Hypovitaminosis D and "functional hypoparathyroidism"—the NoNoF (Nottingham Neck of Femur) study. Age Ageing. 2001 Nov;30(6):467–72.
Seasonal variations in serum levels of 25-hydroxyvitamin D and parathyroid hormone but no detectable change in femoral neck bone density in an older population with regular outdoor exposure. J Am Geriatr Soc. 2001 Sep;49(9):1190–6.
Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001 Aug;22(4):477–501. Review.
Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br J Nutr. 2001 Aug;86 Suppl 1:S97–103.
Vitamin D status affects serum parathyroid hormone concentrations during winter in female adolescents: associations with forearm bone mineral density. Am J Clin Nutr. 2001 Aug;74(2):206–10.
Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab. 2001 Jul;86(7):3086–90.
Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7498–503.
Effect of calcitriol treatment and withdrawal on hyperparathyroidism in haemodialysis patients with hypocalcaemia. Nephrol Dial Transplant. 2001 May;16(5):1009–16.
Serum 25-hydroxyvitamin D and parathyroid hormone in patients with ankylosing spondylitis before and after a three-week rehabilitation treatment at high altitude during winter and spring. Wien Klin Wochenschr. 2001 Apr 30;113(9):328–32.
A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab. 2001 Mar;86(3):1212–21.
Wintertime vitamin D deficiency in male adolescents: effect on parathyroid function and response to vitamin D3 supplements. Osteoporos Int. 2001;12(10):875–9.
Circaannual rhythms and interactions of vitamin D metabolites, parathyroid hormone, and biochemical markers of skeletal homeostasis: a prospective study. J Bone Miner Res. 2000 Dec;15(12):2443–50.
Vitamin D deficiency among immigrants. Ugeskr Laeger. 2000 Nov 13;162(46):6196–9. Review in Danish.
Summer/winter differences in the serum 25-hydroxyvitamin D3 and parathyroid hormone levels of Japanese women. Int J Biometeorol. 2000 Nov;44(4):186–9.
Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population. J Clin Endocrinol Metab. 2000 Nov;85(11):4125–30.
Human 25-hydroxyvitamin D-1alpha-hydroxylase: cloning, mutations, and gene expression. Pediatr Nephrol. 2000 Jul;14(7):620–5. Review.
Vitamin D status: effects on parathyroid hormone and 1, 25-dihydroxyvitamin D in postmenopausal women. Am J Clin Nutr. 2000 Jun;71(6):1577–81.
Severe myopathy associated with vitamin D deficiency in western New York. Arch Intern Med. 2000 Apr 24;160(8):1199–203.
Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab. 2000 Mar;85(3):1054–8.
Prevention of vitamin D deficiency in adolescents and pre-adolescents. An interventional multicenter study on the biological effect of repeated doses of 100,000 IU of vitamin D3. Arch Pediatr. 2000 Feb;7(2):148–53. In French.
Regulation of renal calbindin-D28K. Pharmacol Toxicol. 2000;87 Suppl 3:5–30. Review.
Liver granulomatosis is not an exceptional cause of hypercalcemia with hypoparathyroidism in dialysis patients. J Nephrol. 1999 Nov–Dec;12(6):398–403.
Vitamin D analogs: perspectives for treatment. Miner Electrolyte Metab. 1999 Jul–Dec;25(4–6):337–41. Review.
Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient. Kidney Int. 1999 Jul;56(1):306–17.
Vitamin D status, parathyroid function and femoral bone density in an elderly Swedish population living at home. Aging (Milano). 1999 Jun;11(3):200–7.
Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? Kidney Int. 1999 Jun;55(6):2169–77.
Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2. Am J Kidney Dis. 1998 Oct;32(2 Suppl 2):S48–54.
Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. J Bone Miner Res. 1998 Aug;13(8):1238–42.
19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis. J Am Soc Nephrol. 1998 Aug;9(8):1427–32.
Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout. Metabolism. 1998 Mar;47(3):336–8.
Treatment of vitamin D deficient osteomalacia may unmask autonomous hyperparathyroidism. Postgrad Med J. 1997 Dec;73(866):813–5.
High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology. 1997 Nov;49(5):1273–8.
The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J Bone Miner Res. 1997 Oct;12(10):1552–9.
Saccharated ferric oxide (SFO)-induced osteomalacia: in vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules. Bone. 1997 Jul;21(1):57–64.
Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women. Am J Clin Nutr. 1997 Jan;65(1):67–71.
A crossover comparison of intermittent oral and intravenous administration of calcitriol on the parathyroid hormone concentration in hemodialysis patients. Miner Electrolyte Metab. 1997;23(1):13–8.
Importance of albumin, 25(OH)-vitamin D and IGFBP-3 as risk factors in elderly women and men with hip fracture. Osteoporos Int. 1997;7(5):457–62.
Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism. Am J Kidney Dis. 1996 Nov;28(5):704–12.
Effect of parathyroid hormone (hPTH[1–34]) infusion on serum 1,25-dihydroxyvitamin D and parathyroid hormone in normal women. J Bone Miner Res. 1996 Oct;11(10):1400–5.
Calcitriol and the parathyroid hormone-ionized calcium curve: a comparison of methodologic approaches. J Am Soc Nephrol. 1996 Mar;7(3):497–505.
Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism. Nephrol Dial Transplant. 1996 Jan;11(1):81–7.
Vitamin D deficiency in veterans with chronic spinal cord injury. Metabolism. 1995 Dec;44(12):1612–6.
Compensation for the interracial variance in the cutaneous synthesis of vitamin D. J Lab Clin Med. 1995 Nov;126(5):452–7.
Bone density, vitamin D nutrition, and parathyroid hormone levels in women with dementia. J Am Geriatr Soc. 1995 Oct;43(10):1088–91.
Single-dose cholecalciferol suppresses the winter increase in parathyroid hormone concentrations in healthy older men and women: a randomized trial. Am J Clin Nutr. 1994 May;59(5):1040–4.
Metabolic bone disease in black teenagers with genu valgum or varum without radiologic rickets: a bone histomorphometric study. J Bone Miner Res. 1994 Apr;9(4):479–86.
Suppression of secondary hyperparathyroidism in chronic dialysis patients by single oral weekly dose of 1,25-dihydroxy cholecalciferol. Intern Med. 1993 Sep;32(9):695–701.
Secondary hyperparathyroidism in elderly people: combined effect of renal insufficiency and vitamin D deficiency. Am J Clin Nutr. 1993 Aug;58(2):187–91.
Improvement of secondary hyperparathyroidism and reduction of the set point of calcium after intravenous calcitriol. Kidney Int Suppl. 1993 Jun;41:S125–30.
24,25-dihydroxy vitamin D3 treatment inhibits parathyroid-stimulated adenylate cyclase in iliac crest biopsies from uremic patients. Bone. 1993 Mar-Apr;14(2):125–31.
Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. Miner Electrolyte Metab. 1993;19(2):78–85.
Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med. 1992 Dec 3;327(23):1637–42.
Influence of vitamin D on parathyroid function in the elderly. J Clin Endocrinol Metab. 1992 Aug;75(2):494–501.
Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure. Nephron. 1992;61(4):422–7.
Effect of chronic intravenous calcitriol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism. Nephrol Dial Transplant. 1992;7(8):822–8.
The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients. J Am Soc Nephrol. 1991 Nov;2(5):1014–20.
Lack of relationship between parathyroid hormone and 1,25-dihydroxyvitamin D in chronic renal failure. Nephron. 1991;58(2):144–9.
The 'oral 1,25-dihydroxyvitamin D3 pulse therapy' in hemodialysis patients with severe secondary hyperparathyroidism. Nephron. 1991;57(1):23–8.
Vitamin D status, parathyroid hormone and sunlight in Turkish, Moroccan and Caucasian children in The Netherlands. Eur J Clin Nutr. 1990 Jun;44(6):461–70.
Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis. Kidney Int. 1989 Dec;36(6):1093–8.
Reduced deposition of aluminium in trabecular bone of uraemic rats treated with dihydroxylated vitamin D metabolites. Nephrol Dial Transplant. 1989;4(11):957–65.
Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. J Clin Endocrinol Metab. 1988 Nov;67(5):876–81.
Influence of cadmium on the metabolism of vitamin D3 in rats. Toxicol Appl Pharmacol. 1987 Jun 30;89(2):158–64.
Calcium, vitamin D and parathyroid hormone relationships in pregnant Caucasian and Asian women and their neonates. Ann Clin Biochem. 1987 Jan;24 ( Pt 1):22–8.
Main endocrine modulators of vitamin D hydroxylases in human pathophysiology. J Steroid Biochem. 1987;27(4–6):815–24. Review.
Parathyroid hormone and neonatal calcium homeostasis: evidence for secondary hyperparathyroidism in the Asian neonate. Metabolism. 1986 Sep;35(9):803–6.
The effect of vitamin D on bone in vivo. Endocrinology. 1986 Jun;118(6):2217–24.
Studies on the hydroxylation of vitamin D in man. Ann Med Interne (Paris). 1986;137(3):206–8.
Magnesium administration reverses the hypocalcaemia secondary to hypomagnesaemia despite low circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D. Clin Endocrinol (Oxf). 1985 Jun;22(6):807–15.
Vitamin D metabolism and osteomalacia in cystic fibrosis. Gastroenterology. 1985 Mar;88(3):808–13.
Serum phosphate, parathyroid hormone and vitamin D metabolites in patients with chronic renal failure: effect of aluminum hydroxide administration. Nephron. 1985;40(3):286–91.
Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest. 1984 Dec;74(6):2136–43.
A survey of vitamin D deficiency in gastrointestinal and liver disorders. Q J Med. 1984 Winter;53(209):119–34.
Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest. 1984 Jun;73(6):1580–9.
Vitamin D metabolism and chronic liver disease. Ann Clin Lab Sci. 1984 May–Jun;14(3):189–97. Review.
Vitamin D metabolites and parathyroid hormone in Cushing's syndrome: relationship to calcium and phosphorus homeostasis. J Clin Endocrinol Metab. 1982 May;54(5):1039–44.
Vitamin D and hyperparathyroidism: the Lumleian Lecture 1981. J R Coll Physicians Lond. 1981 Oct;15(4):205–9, 212–7.
A case of hypoparathyroidism in a child with beta-thalassemia successfully treated with 1 alpha-hydroxy-vitamin D3. Helv Paediatr Acta. 1981;36(2):171–3.
Vitamin D metabolism in hypoparathyroidism. J Clin Endocrinol Metab. 1980 Sep;51(3):606–10.
Case report: hypoparathyroidism and iron storage disease. Treatment with 25-hydroxyvitamin D3. Am J Med Sci. 1978 Nov–Dec;276(3):363–8.
1alpha-hydroxycholecalciferol in the treatment of hypoparathyroidism. Acta Med Scand. 1977 Jan;201(1–2):3–7.
Advances in vitamin D metabolism as they pertain to chronic renal disease. Am J Clin Nutr. 1976 Nov;29(11):1283–99.
Vitamin D: the discovery of its metabolites and their therapeutic applications. Pediatrics. 1976 May;57(5):729–41. Review.
Treatment of hypoparathyroidism with 1,25-dihydroxycholecalciferol. Clin Endocrinol (Oxf). 1976;5 Suppl:167S–173S.
Studies of vitamin D deficiency in man. Q J Med. 1975 Oct;44(176):575–89.
Primary hyperparathyroidism associated with nutritional osteomalacia. Am J Med. 1969 Apr;46(4):640–4.

back to research menu

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Unless otherwise expressly stated, all site content licensed under a Creative Commons License.